Status:

UNKNOWN

Three Regimens of Ketamine Infusion in Complex Regional Pain Syndrome

Lead Sponsor:

Tanta University

Conditions:

Ketamine Infusion

Complex Regional Pain Syndromes

Eligibility:

All Genders

21-40 years

Phase:

PHASE4

Brief Summary

To evaluate the efficacy of three regimens of sub anesthetic dose of ketamine infusion in relieving chronic refractory pain in patients with complex regional pain syndrome

Detailed Description

Ketamine N-methyl-D-aspartate (NMDA) receptor blocker that has recently been studied for its analgesic effect is a phencyclidine or phenyl cyclohexyl piperidine (PCP) derivative that initially became ...

Eligibility Criteria

Inclusion

  • Patients aged more than 21 years old of both sexes with American Standards Association I ,II.
  • Patients diagnosed as ( CRPS) based on Budapest criteria
  • The average daily pain intensity required on (NRS) is 7 or more for at least 3 months despite of standard therapy which includes: (pharmacologic therapy as non steroidal anti- inflammatory drugs (NSAIDs), antiepileptic (AEDs), antidepressants), as well as physical therapy and psychiatric care

Exclusion

  • patients refusal
  • Patients with unstable psychological or psychiatric conditions, including : untreated bipolar disorder, post-traumatic stress disorder, major depression , severe personality disorder and psychotic illness.
  • Patients have recently undergone major interventional pain procedures, such as nerve blocks or implantable therapies within 3 months of enrollment.
  • Patients with known drug dependency or substance use disorder specifically related to ketamine or other psycho-stimulant drugs.
  • Patients with previous severe reactions, contraindication or allergy to ketamine.
  • Patients with cardiovascular disease (hypertension, arrhythmia), hepatic, renal or other organ impairment.

Key Trial Info

Start Date :

August 30 2023

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

September 1 2024

Estimated Enrollment :

75 Patients enrolled

Trial Details

Trial ID

NCT05997134

Start Date

August 30 2023

End Date

September 1 2024

Last Update

August 31 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Tanta University

Tanta, El-garbia, Egypt, 31527